CHENNAI: A day after the Lancet report on a drug-resistant superbug NDM-1 created a global scare, India hit out at the study,
which it said was funded by pharma companies that make antibiotics to treat such cases. While the Union health ministry issued a statement on Thursday, which took offence to the naming of the bug after the national capital, the report’s Chennai-based lead authorKarthikeyan Kumarasamy dissociated himself from parts of it.
“The study was funded by the European Union and two pharmaceutical companies, Wellcome Trust and Wyeth, which produce antibiotics for treatment of such cases. It also needs to be highlighted that several of the authors have declared conflict of interest in the publication,” the health ministry said. Read more…
